Open Access
Issue
Vet. Res.
Volume 40, Number 6, November-December 2009
Number of page(s) 15
DOI http://dx.doi.org/10.1051/vetres/2009046
Published online 13 August 2009
How to cite this article Vet. Res. (2009) 40:63
References of  Vet. Res. (2009) 40:63
  1. Bahnemann H.G., Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine, Vaccine (1990) 8:299–303 [CrossRef] [PubMed].
  2. Botner A., Strandbygaard B., Sorensen K.J., Have P., Madsen K.G., Madsen E.S., Alexandersen S., Appearance of acute PRRS-like symptoms in sow herds after vaccination with a modified live PRRS vaccine, Vet. Rec. (1997) 141:497–499 [PubMed].
  3. Christianson W.T., Collins J.E., Benfield D.A., Harris L., Gorcyca D.E., Chladek D.W., et al., Experimental reproduction of swine infertility and respiratory syndrome in pregnant sows, Am. J. Vet. Res. (1992) 53:485–488 [PubMed].
  4. Collins J.E., Benfield D.A., Christianson W.T., Harris L., Hennings J.C., Shaw D.P., et al., Isolation of swine infertility and respiratory syndrome virus (isolate ATCC VR-2332) in North America and experimental reproduction of the disease in gnotobiotic pigs, J. Vet. Diagn. Invest. (1992) 4:117–126 [PubMed].
  5. Delputte P.L., Meerts P., Costers S., Nauwynck H.J., Effect of virus-specific antibodies on attachment, internalization and infection of porcine reproductive and respiratory syndrome virus in primary macrophages, Vet. Immunol. Immunopathol. (2004) 102:179–188 [CrossRef] [PubMed].
  6. Delrue I., Delputte P.L., Nauwynck H.J., Assessing the functionality of viral entry-associated domains of porcine reproductive and respiratory syndrome virus during inactivation procedures, a potential tool to optimize inactivated vaccines, Vet. Res. (2009) 40:62 [CrossRef] [PubMed] [EDP Sciences].
  7. Diaz I., Darwich L., Pappaterra G., Pujols J., Mateu E., Immune responses of pigs after experimental infection with a European strain of Porcine reproductive and respiratory syndrome virus, J. Gen. Virol. (2005) 86:1943–1951 [CrossRef] [PubMed].
  8. Diaz I., Darwich L., Pappaterra G., Pujols J., Mateu E., Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs, Virology (2006) 351:249–259 [CrossRef] [PubMed].
  9. Gorbalenya A.E., Enjuanes L., Ziebuhr J., Snijder E.J., Nidovirales: evolving the largest RNA virus genome, Virus Res. (2006) 117:17–37 [CrossRef] [PubMed].
  10. Labarque G., Van Gucht S., Van Reeth K., Nauwynck H., Pensaert M., Respiratory tract protection upon challenge of pigs vaccinated with attenuated porcine reproductive and respiratory syndrome virus vaccines, Vet. Microbiol. (2003) 95:187–197 [CrossRef] [PubMed].
  11. Labarque G., Reeth K.V., Nauwynck H., Drexler C., Van Gucht S., Pensaert M., Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy, Vaccine (2004) 22:4183–4190 [CrossRef] [PubMed].
  12. Labarque G.G., Nauwynck H.J., Van Reeth K., Pensaert M.B., Effect of cellular changes and onset of humoral immunity on the replication of porcine reproductive and respiratory syndrome virus in the lungs of pigs, J. Gen. Virol. (2000) 81:1327–1334 [PubMed].
  13. Lopez O.J., Osorio F.A., Role of neutralizing antibodies in PRRSV protective immunity, Vet. Immunol. Immunopathol. (2004) 102:155–163 [CrossRef] [PubMed].
  14. Lopez O.J., Oliveira M.F., Garcia E.A., Kwon B.J., Doster A., Osorio F.A., Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent, Clin. Vaccine Immunol. (2007) 14:269–275 [CrossRef] [PubMed].
  15. Mengeling W.L., Lager K.M., Vorwald A.C., Koehler K.J., Strain specificity of the immune response of pigs following vaccination with various strains of porcine reproductive and respiratory syndrome virus, Vet. Microbiol. (2003) 93:13–24 [CrossRef] [PubMed].
  16. Misinzo G., Delputte P.L., Meerts P., Drexler C., Nauwynck H.J., Efficacy of an inactivated PRRSV vaccine: induction of virus-neutralizing antibodies and partial virological protection upon challenge, Adv. Exp. Med. Biol. (2006) 581:449–454 [PubMed].
  17. Neumann E.J., Kliebenstein J.B., Johnson C.D., Mabry J.W., Bush E.J., Seitzinger A.H., et al., Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States, J. Am. Vet. Med. Assoc. (2005) 227:385–392 [CrossRef] [PubMed].
  18. Nielsen H.S., Oleksiewicz M.B., Forsberg R., Stadejek T., Botner A., Storgaard T., Reversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutations, J. Gen. Virol. (2001) 82:1263–1272 [PubMed].
  19. Nilubol D., Platt K.B., Halbur P.G., Torremorell M., Harris D.L., The effect of a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccine treatment on virus shedding in previously PRRSV infected pigs, Vet. Microbiol. (2004) 102:11–18 [CrossRef] [PubMed].
  20. Osorio F.A., Galeota J.A., Nelson E., Brodersen B., Doster A., Wills R., et al., Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity, Virology (2002) 302:9–20 [CrossRef] [PubMed].
  21. Piras F., Bollard S., Laval F., Joisel F., Reynaud G., Charreyre C., et al., Porcine reproductive and respiratory syndrome (PRRS) virus-specific interferongamma(+) T-cell responses after PRRS virus infection or vaccination with an inactivated PRRS vaccine, Viral Immunol. (2005) 18:381–389 [CrossRef] [PubMed].
  22. Scortti M., Prieto C., Martinez-Lobo F.J., Simarro I., Castro J.M., Effects of two commercial European modified-live vaccines against porcine reproductive and respiratory syndrome viruses in pregnant gilts, Vet. J. (2006) 172:506–514 [CrossRef] [PubMed].
  23. Scortti M., Prieto C., Simarro I., Castro J.M., Reproductive performance of gilts following vaccination and subsequent heterologous challenge with European strains of porcine reproductive and respiratory syndrome virus, Theriogenology (2006) 66:1884–1893 [CrossRef] [PubMed].
  24. Scortti M., Prieto C., Alvarez E., Simarro I., Castro J.M., Failure of an inactivated vaccine against porcine reproductive, respiratory syndrome to protect gilts against a heterologous challenge with PRRSV, Vet. Rec. (2007) 161:809–813 [PubMed].
  25. Snijder E.J., Meulenberg J.J., The molecular biology of arteriviruses, J. Gen. Virol. (1998) 79:961–979 [PubMed].
  26. Terpstra C., Wensvoort G., Pol J.M., Experimental reproduction of porcine epidemic abortion and respiratory syndrome (mystery swine disease) by infection with Lelystad virus: Koch's postulates fulfilled, Vet. Q. (1991) 13:131–136 [PubMed].
  27. Thacker E.L., Immunology of the porcine respiratory disease complex, Vet. Clin. North Am. Food Anim. Pract. (2001) 17:551–565 [PubMed].
  28. Van Gucht S., Labarque G., Van Reeth K., The combination of PRRS virus and bacterial endotoxin as a model for multifactorial respiratory disease in pigs, Vet. Immunol. Immunopathol. (2004) 102:165–178 [CrossRef] [PubMed].
  29. Vezina S.A., Loemba H., Fournier M., Dea S., Archambault D., Antibody production and blastogenic response in pigs experimentally infected with porcine reproductive and respiratory syndrome virus, Can. J. Vet. Res. (1996) 60:94–99 [PubMed].
  30. Wensvoort G., Terpstra C., Pol J.M., ter Laak E.A., Bloemraad M., de Kluyver E.P., et al., Mystery swine disease in The Netherlands: the isolation of Lelystad virus, Vet. Q. (1991) 13:121–130 [PubMed].
  31. Wieczorek-Krohmer M., Weiland F., Conzelmann K., Kohl D., Visser N., van Woensel P., et al., Porcine reproductive and respiratory syndrome virus (PRRSV): monoclonal antibodies detect common epitopes on two viral proteins of European and U.S. isolates, Vet. Microbiol. (1996) 51:257–266 [CrossRef] [PubMed].
  32. Wu W.H., Fang Y., Farwell R., Steffen-Bien M., Rowland R.R., Christopher-Hennings J., Nelson E.A., A 10-kDa structural protein of porcine reproductive and respiratory syndrome virus encoded by ORF2b, Virology (2001) 287:183–191 [CrossRef] [PubMed].
  33. Yoon I.J., Joo H.S., Goyal S.M., Molitor T.W., A modified serum neutralization test for the detection of antibody to porcine reproductive and respiratory syndrome virus in swine sera, J. Vet. Diagn. Invest. (1994) 6:289–292 [PubMed].
  34. Yoon K.J., Zimmerman J.J., Swenson S.L., McGinley M.J., Eernisse K.A., Brevik A., et al., Characterization of the humoral immune response to porcine reproductive and respiratory syndrome (PRRS) virus infection, J. Vet. Diagn. Invest. (1995) 7:305–312 [PubMed].
  35. Zuckermann F.A., Garcia E.A., Luque I.D., Christopher-Hennings J., Doster A., Brito M., Osorio F., Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge, Vet. Microbiol. (2007) 123:69–85 [CrossRef] [PubMed].